Answers are grounded in this paper and cite their sources.
Consensus recommendation identifies barriers and solutions for treating hyperkalemia in diverse care settings, indicating educational needs.
In order to understand barriers related to GDMT treatment of hyperkalemia, the RPA convened a nephrology expert panel to review and discuss hyperkalemia across a continuum of care providers and settings. The panel focused on the real-world solutions and identifying opportunities for more education. The panel discussion started with a review of goals, a presentation on the epidemiology of hyperkalemia, and a review of the latest KDIGO Guidelines for Diabetes Management in Chronic Kidney Disease. Following presentations by leading experts in the field, the panelists engaged in a facilitated discussion of incidence and patient management pathways, K+ binders, current KDIGO Guidelines and the ISN Optimization of RAASi Therapy Toolkit, barriers to optimal care, and possible solutions to overcome barriers. Consensus emerged that prescriptive protocols, potassium-restrictive diets and RAASi discontinuation are not appropriate treatments.
No takes yet. Share an insight, caveat, or question.
Palmer et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: